£·¡¥ÁÏÌô¤È¥Ð¥¤¥ª¥¤¥ó¥Õ¥©¥Þ¥Æ¥£¥¯¥¹£·-£±¡¥¹çÍýŪ¤ÊÌôʪÀ߷סÊA1 Principle of Rational Drug Design¡Ë¢£¡¡Ìô¤òÀ߷פ¹¤ë¤È¤Ï¡©
À¸Ì¿ÂΤϡ¢Àµ³Î¤Êʬ»Òǧ¼±¤ª¤è¤Ó¼±Ê̤ˤè¤Ã¤Æ¡¢ÁÈ¿¥¤µ¤ìÀ©¸æ¤µ¤ì¤Æ¤ëʬ»Ò¥·¥¹¥Æ¥à¤Ç¤¹¡£
¸À¤¤´¹¤¨¤ë¤Ê¤é¤Ð¡¢¥¿¥ó¥Ñ¥¯¼Á¤Ê¤É¤Îʬ»Òµ¡³£¤¬Î©ÂÎŪ¤ËºîÍѤ¹¤ë¤³¤È¤Ë¤è¤Ã¤Æ¡¢
À¸Êª¥·¥¹¥Æ¥à¤òÀ®¤êΩ¤¿¤»¤Æ¤¤¤Þ¤¹¡£
¤³¤ì¤Ë¤Ä¤¤¤Æ¤Ï¡¢¡Ö¥¿¥ó¥Ñ¥¯¼Á¤ÎΩÂι½Â¤¤Èµ¡Ç½¡×¤Î¾Ï¤Ç³Îǧ¤·¤Þ¤·¤¿¤¬¡¢ Lock-and-Key Model ¤À¤±¤Ç¤ÏÀâÌÀ¤Ç¤¤Ê¤¤Induced-Fit Model ¤È¸Æ¤Ð¤ì¤ë½ÀÆð¤ÊÁê¸ßºîÍѤâ´Þ¤Þ¤ì¤Æ¤¤¤Þ¤¹¡£ Ìô¤ÎÀ߷פϡ¢¥¿¥ó¥Ñ¥¯¼Á¤Î³èÀÉô°Ì¤Ë¤ª¤±¤ë´±Ç½´ð¤ÎÇÛÃ֤ʤɤǷè¤Þ¤ëÀµ³Î¤Êʬ»Òǧ¼±¤ª¤è¤Ó ʬ»Ò¼±Ê̤ÎÆÃÀ¤òµÕ¤ËÍøÍѤ·¤Æ¹Ô¤¤¤Þ¤¹¡£¤Ä¤Þ¤ê¡¢¥¿¥ó¥Ñ¥¯¼Á¤ÈÁê¸ßºîÍѤ¹¤ë¿·¤·¤¤Ê¬»Ò¤Ë¡¢ ÆÃÄê¤ÎÀ¸ÊªÈ¿±þ¤òÍÞÀ©¤µ¤»¤¿¤ê¡¢Â¥¿Ê¤µ¤»¤¿¤ê¤¹¤ë¤Î¤¬Ìô¤Ê¤Î¤Ç¤¹¡£ Ìô¤ÎÎ㡧¡¡²ÖÊ´¾É¤ÎÌô¤Ç¤¢¤ë¹³¥Ò¥¹¥¿¥ß¥óÌô ¢£¡¡ÁÏÌô¤Î¼ê½ç¡ÊA1.1¡Ë
ÁÏÌô¤Ï¡¢´ðËÜŪ¤Ë¤Ï°Ê²¼¤Î£³¤Ä¤Î¥¹¥Æ¥Ã¥×¤ò·«¤êÊÖ¤¹¤³¤È¤Ç¹Ô¤ï¤ì¤Þ¤¹¡£
![]() ![]() ¢£¡¡Pharmacophore-based Drug Design vs Receptor-based Drug Design¡ÊA1.7¡Ë![]() 1970ǯÂå ɵ¤¤Ë´Ø·¸¤·¤¿¥¿¥ó¥Ñ¥¯¼Á¤ÎΩÂι½Â¤¤Ï¤Þ¤À²òÀϤµ¤ì¤Æ¤ª¤é¤º¡¢ ¥Ú¥Ë¥·¥ê¥ó¤ä¥¹¥Æ¥í¥¤¥É¤È¤¤¤Ã¤¿ºîÍѤ¬ÌÀ¤é¤«¤Ë¤µ¤ì¤Æ¤¤¤ëʪ¼Á¤ò´ð½à¤Ë¸¦µæ¤µ¤ì¤Æ¤¤¤Þ¤·¤¿¡£ ![]() 1980ǯÂå ΩÂι½Â¤¤¬ÌÀ¤é¤«¤Ë¤µ¤ì¤Æ¤¤¤Ê¤¤¥¿¥ó¥Ñ¥¯¼Á¤Ë¤Ä¤¤¤Æ¤â¥Û¥â¥í¥¸¡¼¡¦¥â¥Ç¥ê¥ó¥°¤òÍѤ¤¤ë¤³¤È¤Ë¤è¤ê¥¿¥ó¥Ñ¥¯¼Á¤ÎΩÂι½Â¤¤Ë´ð¤Å¤¤¤¿ À߷פ¬¤Ç¤¤ë¤è¤¦¤Ë¤Ê¤ê¤Þ¤·¤¿¡£ ![]() 1990ǯÂå ÁȤߴ¹¤¨DNA¡¢¥¯¥í¡¼¥Ë¥ó¥°µ»½Ñ¤Îȯã¤Ë¤è¤êÆÃÄê¤Î¥¿¥ó¥Ñ¥¯¼Á¤òÂçÎ̤ËÆþ¼ê¤¹¤ë¤³¤È¤¬¤Ç¤¤ë¤è¤¦¤Ë¤Ê¤ê¡¢ À¸Êª¤Î½ÅÍפʥ¿¥ó¥Ñ¥¯¼Á¤ÎΩÂι½Â¤²òÀϤâÂçÉý¤Ë¿Ê¤ß¤Þ¤·¤¿¡£¤Þ¤¿¡¢Î©Âι½Â¤¤ò¤â¤È¤Ë¤·¤¿ÁÏÌôµ»½Ñ¤âȯŸ¤·¤Æ¤¤Þ¤·¤¿¡£ ![]() 2000ǯÂå ¿¤¯¤ÎɸŪ¥¿¥ó¥Ñ¥¯¼Á¤ÎΩÂι½Â¤¤¬Æþ¼ê²Äǽ¤Ç¤¢¤ê¡¢Receptor-based approach ¤¬Áý¤¨¤Æ¤¤¤Þ¤¹¡£ ¤·¤«¤·¤Ê¤¬¤é¡¢¥³¥ó¥Ó¥Ê¥È¥ê¥¢¥ë¡¦¥±¥ß¥¹¥È¥ê¤ä¥Ï¥¤¥¹¥ë¡¼¥×¥Ã¥È¡¦¥¹¥¯¥ê¡¼¥Ë¥ó¥°¤Ê¤É¤Îµ»½Ñ¤¬ Pharmacophore-based Drug Design ¤Î®ÅÙ¤ò®¤á¤Æ¤¤¤Þ¤¹¡£ ¤µ¤é¤Ë¤³¤ì¤é2¤Ä¤Î¼êË¡¤òÁȤ߹ç¤ï¤»¤ë¤³¤È¤Ë¤è¤Ã¤Æ¡¢¤µ¤é¤Ê¤ë¹â¸úΨ¤òõ¤Ã¤Æ¤¤¤Þ¤¹¡£ ¢£¡¡À½Ìô´ë¶È¤Î£³¼ï¤Î¿À´ï¡Ü¥³¥ó¥Ô¥å¡¼¥¿¡ÊA1.4-5¡Ë
Pharmacophore-based Drug Design ¤Ë Receptor-based Drug Design
¤¬²Ã¤¨¤é¤ì¤Æ¤¤Æ¤¤¤ëÍýͳ¤òÊ̤ΦÌ̤«¤é¤â¸«¤Æ¤ß¤Þ¤·¤ç¤¦¡£
¡Ö¥³¥ó¥Ô¥å¡¼¥¿¤ÇÌô¤òºî¤í¤¦¡×¡¡ÁÏÌô¥Ð¥ê¥å¡¼¥Á¥§¥¤¥óÊÔÃø¡¡¤è¤ê 1990ǯÂå°Ê¹ß¤ÎÀ½Ìô´ë¶È¤Ë¤ª¤¤¤Æ¡¢£³¼ï¤Î¿À´ï ¡ Cominatorial Chemistry¡¢¢ Genomics ¡¢ £HTS¡ÊHigh Throughput Screening¡Ë¤¬ÁÇÁ᤯¿¤¯¤Î¿·Ìô¤ò³«È¯¤¹¤ë¤¿¤á¤ËÍÍѤǤ¢¤ë¤È¤·¤Æ ȯŸ¤·¤Æ¤¤Þ¤·¤¿¡£
³ÆÀ½Ìô²ñ¼Ò¤Ï¡¢¿ô½½Ëü¤«¤é¿ôÉ´Ëü¼ïÎà¤Î²½¹çʪ¤òÊÝͤ·¤Æ¤ª¤ê¡¢¤³¤ì¤é¤ÈɸŪ¥¿¥ó¥Ñ¥¯¼Á¤È¤ÎÁê¸ßºîÍѤˤĤ¤¤ÆÄ´¤Ù¤Ê¤±¤ì¤Ð¤¤¤±¤Þ¤»¤ó¡£ ¤³¤ì¤òÂ絬ÌϤʥí¥Ü¥Ã¥È¤òÍѤ¤¤Æ¹Ô¤Ã¤Æ¤¤¤Þ¤¹¡£1990ǯÂå¤Ë100Ëü¼ï¤Î²½¹çʪ¤Î»î¸³¤Ë£¶¥õ·î¤«¤«¤Ã¤Æ¤¤¤Þ¤·¤¿¤¬¡¢¸½ºß¤Ï£³Æü¤Ç½ª¤ï¤ê¤Þ¤¹¡£ ¤·¤«¤·¡¢¸½¾õ¤ÎHTS¤ÎÈñÍÑÂиú²Ì¤¬ÉÔ½½Ê¬¤È¤Îǧ¼±¤â¶È³¦¤Ë¤Ï¤¢¤ê¤Þ¤¹¡£¤³¤Î¸úΨ¤ò¹â¤á¤ë¤¿¤á¤Î¸¡Æ¤¤ÎÂåɽŪ¤Êή¤ì¤¬ ¡Ö¥³¥ó¥Ô¥å¡¼¥¿¤Ë¤è¤ëÁÏÌô¡×¡¢¤Ä¤Þ¤ê Receptor-based Drug Design ¤Ç¤¹¡£ ¥Ç¡¼¥¿¥Ù¡¼¥¹¤ÎÀ°È÷¤ä¥·¥ß¥å¥ì¡¼¥·¥ç¥óµ»½Ñ¤Î¹âÀºÅÙ²½¤¬ÇطʤȤʤꡢ ɸŪ¥¿¥ó¥Ñ¥¯¼Á¤Î¥ê¥¬¥ó¥É·ë¹çÉô°Ì¤òΩÂÎŪ¡¢ÀÅÅÅŪ¡¢Á¿åŪ¤Ë²òÀϤ·¡¢°åÌôÉÊÀ߷פä¸õÊä²½¹çʪ¤Î¹Ê¤ê¹þ¤ß¤ò ¥³¥ó¥Ô¥å¡¼¥¿¾å¤Ç¹Ô¤¤³ÎÅÙ¤ò¾å¤²¤¿¾å¤Ç¡¢¤½¤Î¸¡¾Ú¤òHTS¤Ç¼Â»Ü¤·¤Æ¤¤¤³¤¦¤È¤¹¤ë¤â¤Î¤Ç¤¹¡£ °ì¤Ä¤Î°åÌôÉʤγ«È¯¤Ë¤«¤«¤ëǯ¿ô¤Ï10¡Á18ǯ¡¢ÈñÍѤÏ500¡Á1000²¯±ß¤¯¤é¤¤¤È¸À¤ï¤ì¤Æ¤¤¤Þ¤¹¡£ ¤³¤Î¤è¤¦¤ÊÃæ¤Ç¡¢ÆüËܤΥȥåפÎÀ½Ìô´ë¶È¤Ç¤âǯ´Ö¤Î¸¦µæ³«È¯Èñ¤Ï2000²¯±ß¤ËÆϤ«¤º¡¢ÆüËܤÎÀ½Ìô¶È³¦Á´ÂΤο·Ìô¤Î³«È¯´Ä¶¤Ï¡¢ ¥Õ¥¡¥¤¥¶¡¼¡¢¥µ¥Î¥Õ¥£¡¦¥¢¥Ù¥ó¥Æ¥£¥¹¡¢¥°¥é¥¯¥½¥¹¥ß¥¹¥¯¥é¥¤¥ó¤Ê¤É¤Î¸¦µæ³«È¯Èñ¤¬Í¥¤Ë5000²¯±ß¤òĶ¤¨¤ë¥á¥¬¥Õ¥¡¡¼¥Þ¤ÈÈæ¤Ù¤Æ¤ß¤ì¤Ð¡¢ Èó¾ï¤Ë¸·¤·¤¤¤È¸À¤¨¤Þ¤¹¡£ ÆüËܤΰåÌôÉÊ»º¶È¤Ë¤ª¤¤¤Æ´üÂÔ¤µ¤ì¤Æ¤¤¤ë¤Î¤Ï¡¢¤Þ¤µ¤Ë¤³¤Î¥³¥ó¥Ô¥å¡¼¥¿¤òÍѤ¤¤¿ Receptor-based Drug Design ¤Ë¤è¤ë´ü´Ö¤Îû½Ì¤È³«È¯Èñ¤Îºï¸º¤Ç¤¹¡£Ë쥿¥ó¥Ñ¥¯¼Á¤Ê¤É¤Î¹½Â¤¤¬Ì¤ÃΤÎɸŪ¥¿¥ó¥Ñ¥¯¼Á¤Ë¤Ä¤¤¤Æ¤Ï¡¢ ¸½Âå¤ÎºÇ¿·¤Î·×»»²Ê³Øµ»½Ñ¤ò¶î»È¤·¤Æ¤µ¤¨¤â¤½¤Î¹½Â¤Í½Â¬¤Ï»ÄÇ°¤Ê¤¬¤é¶Ë¤á¤Æº¤Æñ¤Ç¤¹¤·¡¢¥¿¥ó¥Ñ¥¯¼Á-¥¿¥ó¥Ñ¥¯¼Á¡¢¥¿¥ó¥Ñ¥¯¼Á-DNA¡¢ ¥¿¥ó¥Ñ¥¯¼Á-Á˳²ºÞ¤Ê¤É¤ÎÊ£¹çÂι½Â¤¤òÀµ³Î¤Ëͽ¬¤·¤¿¤ê¤¹¤ë¤³¤È¤âº¤Æñ¤Ç¤¢¤ê¡¢¤Þ¤À¤Þ¤À¸¦µæ¤Î;ÃϤâ»Ä¤µ¤ì¤Æ¤¤¤ë¤Î¤Ç¤¹¡£ |